The average one-year price target for CTI BioPharma Corp is $ The forecasts range from a low of $ to a high of $ A stock's price target is. CTI Biopharma reported $K in Stock for its fiscal quarter ending in December of Data for CTI Biopharma | CTIC - Stock including historical. CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and All stock prices are updated at the end of the day. Institutional Ownership and Shareholders. CTI BioPharma Corp (US:CTIC) has 0 institutional owners and shareholders that have filed 13D/G or 13F forms with the. CTI BioPharma Insider Activity ; Fong James K, 06/25/, 3,, n/a, ; Craig Adam R, 01/23/, 2,, 29,,
Cti Biopharma ; Cyber Threat Intelligence In The Age Of Automation · ByDan SorensenForbes Councils Member ; Will Biopharma Companies Shun Vaccine R&D In A New. CTI BioPharma Corp's current share price is $ This constitutes a share price movement of % when compared to its closing share. The average price target for CTI BioPharma Corp. is $ This is based on 7 Wall Streets Analysts month price targets, issued in the past 3 months. The. Swedish Orphan Biovitrum AB: Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp. CTI BioPharma Corp. (NASDAQ: CTIC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $ price target on the stock. A high-level overview of CTI BioPharma Corp. (CTIC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. CTI BioPharma focuses on the acquisition, development and commercialization of therapies for blood-related cancers that offer unique benefits to patients. CTI BioPharma Corp. (CTIC) - Price History ; March , $, $ ; February , $, $ ; January , $, $ ; December , $, $ CTI BioPharma Corp. ; Prev. Close. ; 52wk Low. ; Market Cap. b ; Total Shares. m ; Shares Out. m. CTI BioPharma Stock Price (Quote) · Historical CTI BioPharma Corp. prices · FAQ.
CTI BioPharma stock (symbol: CTIC) underwent a total of 5 stock splits. The most recent stock split occurred on January 3rd, One CTIC share bought prior. Find the latest CTI BioPharma Corp. (kmega-web.ru) stock quote, history, news and other vital information to help you with your stock trading and investing. The biopharmaceutical company reported ($) earnings per share (EPS) for the quarter, missing the consensus estimate of ($) by $ The. CTIC - CTI BioPharma Corp Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NASDAQ). According to 6 analysts, the average rating for CTIC stock is "Buy." The month stock price forecast is $, which is an increase of % from the latest. Stock price for similar companies or competitors ; CTI BioPharma Logo. Amgen. AMGN. $, % ; CTI BioPharma Logo. Bristol-Myers Squibb. BMY. $, %. CTI BioPharma Corp. (kmega-web.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock CTI BioPharma Corp. | Nyse: CTIC | Nyse. Over the last 12 months, its price rose by percent. Looking ahead, we forecast CTI Biopharma to be priced at by the end of this quarter and at Track CTI BioPharma Corp (CTIC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get.
The intrinsic value of one CTIC stock under the Base Case scenario is USD. Compared to the current market price of USD, CTI Biopharma Corp is. Real time Cti BioPharma (CTIC) stock price quote, stock graph, news & analysis. Create and manipulate a CTI BIOPHARMA (NAQ:CTIC) stock price chart, with moving average, RSI & MACD overlays. Add your portfolio transactions. Get CTi Biopharma Corp historical price data for CTIC stock. kmega-web.ru has all the historical stock data including the closing price, open, high, low. Ratings analysis incomplete due to data availability. Recommendations not provided. Maximize Income Goal. See Best High Dividend Stocks Model Portfolio for our.
Economist Definition | Lost My W2 From Last Year